Markets:

Overview

News

Currencies

International

Treasuries

Abeona Therapeutics Inc. - Common Stock (NQ:ABEO)

5.965 -0.385 (-6.06%)

Streaming Delayed Price Updated: 11:26 AM EDT, Aug 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abeona Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

20 Stocks Moving in Friday's Pre-Market Session ↗

December 17, 2021

Gainers Genfit SA (NASDAQ: GNFT) rose 47.5% to $4.90 in pre-market trading. Ipsen and GENFIT reported an exclusive licensing agreement for Elafibranor. Spruce Biosciences, Inc. (...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 16, 2021

Gainers Eloxx Pharmaceuticals (NASDAQ:

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 02, 2021

Good morning, trader! We're gearing up for another busy day of trading with the biggest pre-market stock movers for Thursday!

Via InvestorPlace

3 Penny Stocks That Wall Street Wants You To Buy Now ↗

April 21, 2021

Penny stocks are very risky, which is why they have such low prices. Many of the companies in this risky part of the market will go bankrupt. ...

Via Benzinga

Topics Bankruptcy

Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021 ↗

November 30, 2021

Upgrades Sidoti & Co. upgraded the previous rating for DMC Global Inc (NASDAQ:

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

November 29, 2021

Citigroup cut Merck & Co., Inc. (NYSE: MRK) price target from $105 to $85. Merck shares fell 2% to $77.55 in pre-market trading. Keybanc lowered Arista Networks, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug ↗

November 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Synlogic Presents Positive Phase 2 Data For Synthetic Biologic Treatment In...

Via Benzinga

The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week ↗

November 21, 2021

Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 15, 2021

Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!

Via InvestorPlace

The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO ↗

October 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine...

Via Benzinga

The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs ↗

October 18, 2021

Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 05, 2021

Gainers Synaptogenix (NASDAQ:SNPX) stock...

Via Benzinga

Abeona Stock Gains As It Concludes Type B Meeting With FDA For MPS IIIA Gene Therapy ↗

July 28, 2021

Abeona Therapeutics Inc (NASDAQ: ABEO) has completed a Type B meeting with the FDA regarding the pivotal trial for its ABO-102 gene therapy for Sanfilippo syndrome...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 28, 2021

Gainers Infinity Pharmaceuticals (NASDAQ:INFI) shares moved upwards by 40.13% to $2.13 during Wednesday's pre-market session. The company's market cap stands at $...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

34 Stocks Moving in Tuesday's Pre-Market Session ↗

July 27, 2021

Gainers Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) shares rose 139.7% to $7.48 in pre-market trading after the company announced it entered a non-binding letter of intent to...

Via Benzinga

48 Stocks Moving In Monday's Mid-Day Session ↗

July 26, 2021

Gainers Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic co-mining agreement with Digihost Technology Inc. The...

Via Benzinga

Abeona Stock Moves Higher After MPS IIIA Gene Therapy Shows Increase In Brain Volume ↗

July 26, 2021

Abeona Therapeutics Inc (NASDAQ: ABEO) announced magnetic resonance imaging (MRI) data from the Phase 1/2 Transpher A study of ABO-102 gene therapy in Sanfilippo...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 26, 2021

Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million....

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

July 19, 2021

Goldman Sachs boosted QUALCOMM Incorporated (NASDAQ: QCOM) price target from $136 to $148. QUALCOMM shares rose 0.6% to $140.50 in pre-market trading. Stephens & Co. lifted...

Via Benzinga

Abeona Unveils Additional Data From Gene Therapy Trial For Rare Connective Tissue Disorder ↗

July 07, 2021

Abeona Therapeutics Inc (NASDAQ: ABEO) has announced updated data from Phase 1/2a trial for up to six years following treatment with EB-101 for recessive...

Via Benzinga

46 Stocks Moving In Thursday's Mid-Day Session ↗

June 03, 2021

Gainers GTT Communications, Inc. (NYSE: GTT) shares jumped 66% to $4.16 on abnormally-high volume. The company’s stock also jumped over 57% on Wednesday. Ra Medical Systems...

Via Benzinga

28 Stocks Moving in Thursday's Pre-Market Session ↗

June 03, 2021

Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 18, 2021

Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 41.84% to $0.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 07, 2021

Gainers Protagenic Therapeutics (NASDAQ:PTIX

Via Benzinga

Abeona Therapeutics Inc. (NASDAQ:ABEO) Investor Alert: Investigation over Potential Wrongdoing ↗

April 08, 2021

San Diego, CA -- (SBWIRE) -- 04/08/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Abeona Therapeutics Inc.

Via SBWire

64 Biggest Movers From Yesterday ↗

May 05, 2021

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.